No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment

No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment

To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI).

Bibliographic Details
Main Authors: Hung, Tsung-Hsing, Tsai, Chen-Chi, Tseng, Chih-Wei, Tseng, Kuo-Chih, Hsieh, Yu-Hsi, Tsai, Chih-Chun
Format: Online
Language:English
Published: Lippincott Williams And Wilkins 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051540/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051540/

Similar Items